Hoya (TYO:7741) began a strategic review of its medical endoscope business to optimize the company's portfolio and improve capital efficiency, according to a Friday filing with the Korea Exchange.
The PENTAX Medical business has domestic and overseas operations.
Hoya is reviewing options, including a potential sale of the business to a third party.
Domestic operations of the PENTAX Medical business will be transferred to a wholly owned subsidiary via an absorption-type company split, effective Saturday, Aug. 1.